欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/4044/001
药品名称MEROPENEM 500 mg, powder for solution for injection or infusion
活性成分
    • Meropenem trihydrate 500.0 mg
剂型Powder for solution for infusion
上市许可持有人Sun Pharmaceutical Industries Europe B.V. Polarisavenue 87 2132JH Hoofddorp Nederland
参考成员国 - 产品名称Netherlands (NL)
Meropenem 500 mg Ranbaxy, poeder voor injectievloeistof
互认成员国 - 产品名称
    • Germany (DE)
      MEROPENEM MRC 500 mg Pulver zur Herstellung einer Injektions- oder Infusionslösung
    • Denmark (DK)
    • Poland (PL)
      Nableran
    • Lithuania (LT)
      MEROPENEM RANBAXY 500 mg milteliai injekciniam ar infuziniam tirpalui
    • Romania (RO)
      LODITER 500 mg, pulbere pentru solutie injectabila intravenoasa/perfuzabila
    • Latvia (LV)
    • Iceland (IS)
    • Finland (FI)
      Mereopenem Sun
    • Norway (NO)
    • Sweden (SE)
    • Estonia (EE)
      Meropenem Sun
    • Italy (IT)
许可日期2010/09/09
最近更新日期2024/10/30
药物ATC编码
    • J01DH02 meropenem
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：[not specified]
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase